Thompson Siegel & Walmsley’s Myriad Genetics MYGN Stock Holding History

Thompson Siegel & Walmsley’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-328	Closed	-$9K	–	741
2019 Q4	$9K	Hold	328	–	–	﹤0.01%	638
2019 Q3	$9K	Hold	328	–	–	﹤0.01%	649
2019 Q2	$9K	Hold	328	–	–	﹤0.01%	657
2019 Q1	$11K	Hold	328	–	–	﹤0.01%	592
2018 Q4	$10K	Hold	328	–	–	﹤0.01%	642
2018 Q3	$15K	Hold	328	–	–	﹤0.01%	641
2018 Q2	$12K	Hold	328	–	–	﹤0.01%	680
2018 Q1	$10K	Hold	328	–	–	﹤0.01%	685
2017 Q4	$11K	Hold	328	–	–	﹤0.01%	706
2017 Q3	$12K	Hold	328	–	–	﹤0.01%	695
2017 Q2	$8K	Hold	328	–	–	﹤0.01%	722
2017 Q1	$6K	Buy	+328	New	+$5.81K	﹤0.01%	742

Other funds holding MYGN

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return